Compare TILE & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TILE | PAHC |
|---|---|---|
| Founded | 1973 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 1994 | 2014 |
| Metric | TILE | PAHC |
|---|---|---|
| Price | $27.78 | $49.49 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | ★ $36.00 | $34.33 |
| AVG Volume (30 Days) | ★ 410.3K | 217.5K |
| Earning Date | 05-27-2026 | 05-06-2026 |
| Dividend Yield | 0.29% | ★ 0.98% |
| EPS Growth | 32.43 | ★ 1883.33 |
| EPS | ★ 1.96 | 1.32 |
| Revenue | ★ $1,386,854,000.00 | $833,350,000.00 |
| Revenue This Year | $7.00 | $17.03 |
| Revenue Next Year | $5.46 | $3.82 |
| P/E Ratio | ★ $14.11 | $37.12 |
| Revenue Growth | ★ 5.41 | 4.12 |
| 52 Week Low | $17.31 | $16.16 |
| 52 Week High | $35.11 | $56.30 |
| Indicator | TILE | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 28.97 | 50.20 |
| Support Level | $27.55 | $37.09 |
| Resistance Level | $28.87 | $56.14 |
| Average True Range (ATR) | 0.99 | 2.22 |
| MACD | -0.37 | -0.76 |
| Stochastic Oscillator | 15.50 | 35.46 |
Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.